世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

アジア太平洋地域の神経血管デバイス／インターベンショナル・ニューロロジー市場予測 2023-2032

アジア太平洋地域の神経血管デバイス／インターベンショナル・ニューロロジー市場予測 2023-2032


ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET FORECAST 2023-2032

主な調査結果 アジア太平洋地域の神経血管装置/介入神経学市場は、2023年から2032年の予測期間中にCAGR 5.46％で成長すると評価されている。同地域の市場成長を増大させる主な要因には、老年人口の急増や神経血... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
Inkwood Research
インクウッドリサーチ 		2023年8月4日 US$1,600
シングルユーザライセンス（印刷不可）
ライセンス・価格情報
注文方法はこちら 		2-3営業日以内 161 英語

　

サマリー

主な調査結果
アジア太平洋地域の神経血管装置/介入神経学市場は、2023年から2032年の予測期間中にCAGR 5.46％で成長すると評価されている。同地域の市場成長を増大させる主な要因には、老年人口の急増や神経血管インターベンションに対する意識の高まりなどがある。
市場インサイト
インドネシア、タイ、ベトナム、オーストラリア＆ニュージーランド、中国、日本、インド、韓国、その他のアジア太平洋地域は、アジア太平洋地域の神経血管装置／介入神経学市場成長評価の対象である。インドでは、神経疾患は全疾患の10％を占め、同国全体の疾病負担に大きく寄与している。予防戦略の欠如や未組織の脳卒中管理により、神経血管疾患の有病率は上昇傾向にある。さらに、負担、大気汚染、高血圧、食生活の乱れ、高体重指数のような確立された危険因子は、神経疾患の主な原因の一つである。
インドにおける血管内治療法市場も著しい成長を遂げている。血管内コイリングの急速な普及は、インターベンショナル神経放射線学にさらなる変革をもたらした。インドでは、神経疾患の有病率を低下させるために、いくつかの政府プログラムやイニシアチブが重視されているが、各州で専門的な神経学サービスを発展させるためには、協調的な取り組みが必要である。熟練した神経学の専門家の不足に対処し、これらの疾患の早期診断と費用対効果の高い管理を強化することは、国内で増大する神経疾患の負担に対処するための重要なステップである。したがって、前述の要因がアジア太平洋地域の神経血管装置/介入型神経学市場の成長を促進すると予測される。
競合他社の洞察
市場に参入している主要企業には、テルモ株式会社、株式会社カネカなどが含まれる。
当レポートの提供内容は以下の通りです：
- 市場全体の主要調査結果を探る
- 市場ダイナミクスの戦略的内訳（促進要因、阻害要因、機会、課題）
- 全セグメント、サブセグメント、地域の3年間の過去データとともに、最低9年間の市場予測
- 市場セグメンテーション：主要セグメントの徹底的な評価と市場予測
- 地域別分析：言及された地域と国レベルのセグメントを市場シェアとともに評価
- 主要分析：ポーターのファイブフォース分析、ベンダーランドスケープ、オポチュニティマトリックス、主要購買基準など。
- 競争環境は、要因や市場シェアなどに基づく主要企業の理論的説明である。
- 企業プロファイリング：詳細な会社概要、提供する製品・サービス、SCOT分析、最近の戦略的展開など


ページTOPに戻る


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
2.5.2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
2.5.3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS
3.1.2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
3.1.3. GERIATRIC POPULATION’S VULNERABILITY TO NEUROVASCULAR DISEASES
3.1.4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
3.2. KEY RESTRAINTS
3.2.1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
3.2.2. LACK OF TRAINED NEUROSURGEONS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR THAILAND
4.4. MARKET CONCENTRATION ANALYSIS
4.5. VALUE CHAIN ANALYSIS
5. MARKET BY PRODUCT
5.1. EMBOLIZATION DEVICES
5.1.1. EMBOLIC COILS
5.1.1.1. COATED DETACHABLE COILS
5.1.1.2. BARE DETACHABLE COILS
5.1.2. COIL ASSIST STENT
5.1.3. CLIPPINGS
5.1.4. COIL ASSIST BALLOON
5.2. ACCESSORY DEVICES
5.2.1. MICROCATHETERS
5.2.2. MICRO GUIDEWIRES
5.3. REVASCULARIZATION DEVICES
5.3.1. CAROTID ARTERY STENTS
5.3.2. FLOW DIVERSION STENTS
5.4. THROMBECTOMY DEVICES
5.4.1. CLOT RETRIEVAL DEVICES
5.4.2. SUCTION AND ASPIRATION DEVICES
5.4.3. SNARES
5.5. EMBOLIC PROTECTION DEVICES
5.5.1. BALLOON OCCLUSION DEVICES
5.5.2. DISTAL FILTER DEVICES
6. MARKET BY APPLICATION
6.1. ANEURYSM
6.2. ISCHEMIC STROKE
6.3. STENOSIS
6.4. ARTERIOVENOUS MALFORMATION (AVM)
6.5. OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA-PACIFIC
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.1.3. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.1.4. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.1.5. KEY PLAYERS IN ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.1.6. COUNTRY ANALYSIS
7.1.6.1. CHINA
7.1.6.1.1. CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.2. JAPAN
7.1.6.2.1. JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.3. INDIA
7.1.6.3.1. INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.4. SOUTH KOREA
7.1.6.4.1. SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.5. INDONESIA
7.1.6.5.1. INDONESIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.6. THAILAND
7.1.6.6.1. THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.7. VIETNAM
7.1.6.7.1. VIETNAM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.8. AUSTRALIA & NEW ZEALAND
7.1.6.8.1. AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.9. REST OF ASIA-PACIFIC
7.1.6.9.1. REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. ACANDIS GMBH
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCT LIST
8.2.2. ASAHI INTECC
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCT LIST
8.2.3. BALT
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCT LIST
8.2.4. B BRAUN MELSUNGEN AG
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCT LIST
8.2.4.3. STRENGTHS & CHALLENGES
8.2.5. INTEGER HOLDINGS CORPORATION
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCT LIST
8.2.5.3. STRENGTHS & CHALLENGES
8.2.6. JOHNSON & JOHNSON (CERENOVUS)
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCT LIST
8.2.6.3. STRENGTHS & CHALLENGES
8.2.7. KANEKA CORPORATION
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCT LIST
8.2.8. MEDTRONIC INC
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCT LIST
8.2.8.3. STRENGTHS & CHALLENGES
8.2.9. MEMRY CORPORATION
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCT LIST
8.2.10. MICROPORT SCIENTIFIC CORPORATION
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCT LIST
8.2.10.3. STRENGTHS & CHALLENGES
8.2.11. PENUMBRA INC
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCT LIST
8.2.12. PHENOX INC
8.2.12.1. COMPANY OVERVIEW
8.2.12.2. PRODUCT LIST
8.2.12.3. STRENGTHS & CHALLENGES
8.2.13. RAPID MEDICAL
8.2.13.1. COMPANY OVERVIEW
8.2.13.2. PRODUCT LIST
8.2.13.3. STRENGTHS & CHALLENGES
8.2.14. SENSOME
8.2.14.1. COMPANY OVERVIEW
8.2.14.2. PRODUCT LIST
8.2.14.3. STRENGTHS & CHALLENGES
8.2.15. STRYKER CORPORATION
8.2.15.1. COMPANY OVERVIEW
8.2.15.2. PRODUCT LIST
8.2.15.3. STRENGTHS & CHALLENGES
8.2.16. TERUMO CORPORATION
8.2.16.1. COMPANY OVERVIEW
8.2.16.2. PRODUCT LIST
8.2.16.3. STRENGTHS & CHALLENGES

　

ページTOPに戻る


　

Summary

KEY FINDINGS
The Asia-Pacific neurovascular devices/interventional neurology market is evaluated to develop with a CAGR of 5.46% during the projection period of 2023 to 2032. Some of the leading factors augmenting the market growth of the region include a surge in the geriatric populace as well as the rising awareness about neurovascular interventions.
MARKET INSIGHTS
Indonesia, Thailand, Vietnam, Australia & New Zealand, China, Japan, India, South Korea, and Rest of Asia-Pacific are covered under the Asia-Pacific neurovascular devices/interventional neurology market growth assessment. In India, neurological illnesses account for a significant 10% of all diseases, contributing substantially to the country’s overall disease burden. The prevalence of neurovascular diseases is on the rise due to the lack of preventive strategies and unorganized stroke management. Moreover, established risk factors like burden, air pollution, high blood pressure, dietary hazards, and high body mass index are among the primary causes of neurological illnesses.
The market for endovascular treatment methods in India is witnessing remarkable growth, as well. The rapid adoption of endovascular coiling has further led to a transformation in interventional neuroradiology. While several government programs and initiatives are focused on reducing the prevalence of neurological illnesses in India, concerted efforts are needed to develop specialized neurology services in each state. Addressing the scarcity of skilled neurology professionals and enhancing early diagnosis and cost-effective management of these conditions are crucial steps to cope with the growing burden of neurological disorders in the nation. Hence, the aforementioned factors are projected to fuel the Asia-Pacific neurovascular devices/interventional neurology market growth.
COMPETITIVE INSIGHTS
Key firms operating in the market include Terumo Corporation, Kaneka Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. GOVERNMENT INITIATIVES TO CREATE AWARENESS ABOUT NEUROVASCULAR DISEASES
2.5.2. EARLY DETECTION OF ARTERIOVENOUS MALFORMATION (AVM)
2.5.3. THROMBECTOMY IMPROVES PATIENT OUTCOMES AND REDUCES DISABILITY RATE
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SIGNIFICANT RISE IN INCIDENCE OF NEUROVASCULAR CONDITIONS
3.1.2. PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
3.1.3. GERIATRIC POPULATION’S VULNERABILITY TO NEUROVASCULAR DISEASES
3.1.4. UNDERLYING DISEASES ARE A RISK FACTOR FOR NEUROVASCULAR DISEASES
3.2. KEY RESTRAINTS
3.2.1. EXORBITANT COSTS OF NEUROVASCULAR DEVICES
3.2.2. LACK OF TRAINED NEUROSURGEONS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR THAILAND
4.4. MARKET CONCENTRATION ANALYSIS
4.5. VALUE CHAIN ANALYSIS
5. MARKET BY PRODUCT
5.1. EMBOLIZATION DEVICES
5.1.1. EMBOLIC COILS
5.1.1.1. COATED DETACHABLE COILS
5.1.1.2. BARE DETACHABLE COILS
5.1.2. COIL ASSIST STENT
5.1.3. CLIPPINGS
5.1.4. COIL ASSIST BALLOON
5.2. ACCESSORY DEVICES
5.2.1. MICROCATHETERS
5.2.2. MICRO GUIDEWIRES
5.3. REVASCULARIZATION DEVICES
5.3.1. CAROTID ARTERY STENTS
5.3.2. FLOW DIVERSION STENTS
5.4. THROMBECTOMY DEVICES
5.4.1. CLOT RETRIEVAL DEVICES
5.4.2. SUCTION AND ASPIRATION DEVICES
5.4.3. SNARES
5.5. EMBOLIC PROTECTION DEVICES
5.5.1. BALLOON OCCLUSION DEVICES
5.5.2. DISTAL FILTER DEVICES
6. MARKET BY APPLICATION
6.1. ANEURYSM
6.2. ISCHEMIC STROKE
6.3. STENOSIS
6.4. ARTERIOVENOUS MALFORMATION (AVM)
6.5. OTHER APPLICATIONS
7. GEOGRAPHICAL ANALYSIS
7.1. ASIA-PACIFIC
7.1.1. MARKET SIZE & ESTIMATES
7.1.2. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET DRIVERS
7.1.3. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET CHALLENGES
7.1.4. ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET REGULATORY FRAMEWORK
7.1.5. KEY PLAYERS IN ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET
7.1.6. COUNTRY ANALYSIS
7.1.6.1. CHINA
7.1.6.1.1. CHINA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.2. JAPAN
7.1.6.2.1. JAPAN NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.3. INDIA
7.1.6.3.1. INDIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.4. SOUTH KOREA
7.1.6.4.1. SOUTH KOREA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.5. INDONESIA
7.1.6.5.1. INDONESIA NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.6. THAILAND
7.1.6.6.1. THAILAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.7. VIETNAM
7.1.6.7.1. VIETNAM NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.8. AUSTRALIA & NEW ZEALAND
7.1.6.8.1. AUSTRALIA & NEW ZEALAND NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
7.1.6.9. REST OF ASIA-PACIFIC
7.1.6.9.1. REST OF ASIA-PACIFIC NEUROVASCULAR DEVICES/INTERVENTIONAL NEUROLOGY MARKET SIZE & OPPORTUNITIES
8. COMPETITIVE LANDSCAPE
8.1. KEY STRATEGIC DEVELOPMENTS
8.1.1. MERGERS & ACQUISITIONS
8.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
8.1.3. PARTNERSHIPS & AGREEMENTS
8.1.4. BUSINESS EXPANSIONS & DIVESTITURES
8.2. COMPANY PROFILES
8.2.1. ACANDIS GMBH
8.2.1.1. COMPANY OVERVIEW
8.2.1.2. PRODUCT LIST
8.2.2. ASAHI INTECC
8.2.2.1. COMPANY OVERVIEW
8.2.2.2. PRODUCT LIST
8.2.3. BALT
8.2.3.1. COMPANY OVERVIEW
8.2.3.2. PRODUCT LIST
8.2.4. B BRAUN MELSUNGEN AG
8.2.4.1. COMPANY OVERVIEW
8.2.4.2. PRODUCT LIST
8.2.4.3. STRENGTHS & CHALLENGES
8.2.5. INTEGER HOLDINGS CORPORATION
8.2.5.1. COMPANY OVERVIEW
8.2.5.2. PRODUCT LIST
8.2.5.3. STRENGTHS & CHALLENGES
8.2.6. JOHNSON & JOHNSON (CERENOVUS)
8.2.6.1. COMPANY OVERVIEW
8.2.6.2. PRODUCT LIST
8.2.6.3. STRENGTHS & CHALLENGES
8.2.7. KANEKA CORPORATION
8.2.7.1. COMPANY OVERVIEW
8.2.7.2. PRODUCT LIST
8.2.8. MEDTRONIC INC
8.2.8.1. COMPANY OVERVIEW
8.2.8.2. PRODUCT LIST
8.2.8.3. STRENGTHS & CHALLENGES
8.2.9. MEMRY CORPORATION
8.2.9.1. COMPANY OVERVIEW
8.2.9.2. PRODUCT LIST
8.2.10. MICROPORT SCIENTIFIC CORPORATION
8.2.10.1. COMPANY OVERVIEW
8.2.10.2. PRODUCT LIST
8.2.10.3. STRENGTHS & CHALLENGES
8.2.11. PENUMBRA INC
8.2.11.1. COMPANY OVERVIEW
8.2.11.2. PRODUCT LIST
8.2.12. PHENOX INC
8.2.12.1. COMPANY OVERVIEW
8.2.12.2. PRODUCT LIST
8.2.12.3. STRENGTHS & CHALLENGES
8.2.13. RAPID MEDICAL
8.2.13.1. COMPANY OVERVIEW
8.2.13.2. PRODUCT LIST
8.2.13.3. STRENGTHS & CHALLENGES
8.2.14. SENSOME
8.2.14.1. COMPANY OVERVIEW
8.2.14.2. PRODUCT LIST
8.2.14.3. STRENGTHS & CHALLENGES
8.2.15. STRYKER CORPORATION
8.2.15.1. COMPANY OVERVIEW
8.2.15.2. PRODUCT LIST
8.2.15.3. STRENGTHS & CHALLENGES
8.2.16. TERUMO CORPORATION
8.2.16.1. COMPANY OVERVIEW
8.2.16.2. PRODUCT LIST
8.2.16.3. STRENGTHS & CHALLENGES

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Inkwood Research社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:630 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68d51da90169e8_18903235() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68b0f61a4d9868_07068969() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 630